Íàèìåíîâàíèå | Ïðîèçâîäèòåëü | Öåíà $ | Öåíà ðóá
|
---|
ÀÊÐÈÄÅÐÌ ÃÊ ÊÐÅÌ 15Ã | "ÀÊÐÈÕÈÍ" ÕÔÊ ÎÀÎ | | 205.73
|
ÀÊÐÈÄÅÐÌ ÑÊ ÌÀÇÜ 30Ã | "ÀÊÐÈÕÈÍ" ÕÔÊ ÎÀÎ | | 136.01
|
ÀÊÐÈÄÅÐÌ ÌÀÇÜ 0,064% 15Ã | "ÀÊÐÈÕÈÍ" ÕÔÊ ÎÀÎ | | 57.57
|
ÀÊÑÀÌÎÍ ÒÀÁ. 0,02 ¹50 | "ÏÈÊ-ÔÀÐÌÀ" | | 249
|
ÀÊÒÈÔÅÐÐÈÍ ÊÀÏËÈ ÔË.¹30 | RATIOPHARM/MERCKLE | | 76.83
|
ÀÊÒÈÔÅÐÐÈÍ ÊÀÏÑ. ¹20 | RATIOPHARM/MERCKLE | | 60.46
|
ÀÊÒÈÔÅÐÐÈÍ ÊÀÏÑ. ¹50 | RATIOPHARM/MERCKLE | | 118.02
|
ÀÊÒÈÔÅÐÐÈÍ ÑÈÐÎÏ 100ÌË | RATIOPHARM/MERCKLE | | 94.84
|
ÀÊÒÈÔÅÐÐÈÍ-ÊÎÌÏÎÇÈÒÓÌ ÊÀÏÑ.¹30 | RATIOPHARM/MERCKLE | | 85.82
|
ÀÊÒÎÂÅÃÈÍ 10% Ð-Ð Ä/ÈÍ 4ÌÃ/ÌË 250ÌË | NYCOMED | | 500.67
|
ÀÊÒÎÂÅÃÈÍ 20% Ð-Ð Ä/ÈÍ 8ÌÃ/ÌË 250ÌË | NYCOMED | | 583.03
|
ÀÊÒÎÂÅÃÈÍ ÃÅËÜ Ä/ÍÀÐ.ÏÐÈÌ.20% 20Ã | NYCOMED | | 133.12
|
ÀÊÒÎÂÅÃÈÍ ÊÐÅÌ Ä/ÍÀÐÓÆ.ÏÐÈÌ. 5% 20Ã ÒÓÁÛ | NYCOMED | | 95.22
|
ÀÊÒÎÂÅÃÈÍ ÌÀÇÜ Ä/ÍÀÐ.ÏÐÈÌ. 5% 20Ã. | NYCOMED | | 81.56
|
ÀÊÒÎÂÅÃÈÍ Ð-Ð ÀÌÏ. 40ÌÃ/ÌË 2ÌË ¹25 | NYCOMED | | 823.29
|
ÀÊÒÎÂÅÃÈÍ Ð-Ð Ä/ÈÍ.40ÌÃ/ÌË.-5ÌË. ÀÌÏ.¹5 | NYCOMED | | 403.47
|
ÀËÊÀ-ÇÅËÜÒÖÅÐ ÒÀÁ.ØÈÏ.¹10 | BAYER AG | | 118.84
|
ÀËËÅÐÃÎÄÈË ÊÀÏËÈ ÃËÀÇÍ. ÔË.-ÊÀÏ. 0,05% 6ÌË | TUBILUX PHARMA S.P.A. | | 215.56
|
ÀËËÅÐÃÎÄÈË ÑÏÐÅÉ ÍÀÇ. 140ÌÊÃ/ÄÎÇÀ 10ÌË ÔËÀÊ. Ñ ÄÎÇÀÒ.-ÐÀÑÏ.¹1 | MEDA PHARMA GMBH&CO.KG | | 186.45
|
ÀËËÎÏÓÐÈÍÎË ÒÀÁË. 100ÌÃ ¹50 | "ÎÐÃÀÍÈÊÀ" ÎÀÎ | | 62.7
|
ÀËËÎÕÎË ÒÀÁ Ï/Î ¹50 | "ÈÐÁÈÒÑÊÈÉ ÕÔÇ" | | 55
|